Pharmacologic synergism of ocular ketorolac and systemic caffeine citrate in rat oxygen-induced retinopathy

Pediatr Res. 2016 Oct;80(4):554-65. doi: 10.1038/pr.2016.105. Epub 2016 May 16.

Abstract

Background: Caffeine or ketorolac decrease the risk of retinopathy of prematurity and may act synergistically to improve beneficial effect. Combination of caffeine (Caff) and ketorolac (Keto) to prevent oxygen-induced retinopathy was studied.

Methods: Newborn rats exposed to room air (RA) or intermittent hypoxia (IH) consisting of 12% O2 during hyperoxia (50% O2) from birth (P0) had single daily IP injections of Caff from P0-P13 or saline; and/or ocular Keto (Acuvail, 0.45% ophthalmic solution) administered subcutaneously over the eyes from P5-P7. Pups were studied at P14 or placed in RA for recovery from IH (IHR) until P21. Eyes were examined for neovascularization, histopathology, growth factors, and VEGF-signaling genes.

Results: Severe retinal damage noted during IHR in the untreated groups evidenced by hemorrhage, neovascularization, and oxygen-induced retinopathy (OIR) pathologies were prevented with Keto/Caff treatment. Keto and/or Caff treatment in IH also promoted retinal neural development evidenced by eye opening (92%, P < 0.001 vs. 31% in the placebo-treated IH group). No corneal pathologies were noted with Keto.

Conclusion: Caff or Keto given individually reduced retinal neovascularization, but the two drugs given together prevented severe OIR.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Animals, Newborn
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Apyrase / metabolism
  • Arteries / metabolism
  • Body Weight
  • Caffeine / administration & dosage*
  • Central Nervous System Stimulants / administration & dosage
  • Choroid / metabolism
  • Citrates / administration & dosage*
  • Dinoprost / analogs & derivatives
  • Dinoprost / metabolism
  • Drug Synergism
  • Female
  • Hemorrhage
  • Hypoxia-Inducible Factor 1, alpha Subunit / blood
  • Insulin-Like Growth Factor I / metabolism
  • Intercellular Signaling Peptides and Proteins / metabolism
  • Ketorolac / administration & dosage*
  • Neovascularization, Pathologic
  • Oxygen / adverse effects*
  • Rats
  • Rats, Sprague-Dawley
  • Retina / metabolism
  • Retinopathy of Prematurity / chemically induced
  • Retinopathy of Prematurity / drug therapy*
  • Signal Transduction
  • Time Factors
  • Vascular Endothelial Growth Factor A / metabolism
  • Vascular Endothelial Growth Factor Receptor-1 / blood

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Central Nervous System Stimulants
  • Citrates
  • Hif1a protein, rat
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Intercellular Signaling Peptides and Proteins
  • Vascular Endothelial Growth Factor A
  • insulin-like growth factor-1, rat
  • 8-epi-prostaglandin F2alpha
  • Caffeine
  • Insulin-Like Growth Factor I
  • Dinoprost
  • Vascular Endothelial Growth Factor Receptor-1
  • Apyrase
  • Oxygen
  • caffeine citrate
  • Ketorolac